Filing search / Longboard Pharmaceuticals, Inc. / "R&D" / Page 2

8-K

EX-99.1

bsg71v22

5 May 22

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results

12:00am

10-K

91f2x9 yk9sbc

3 Mar 22

Annual report

4:31pm

8-K

EX-99.1

39ofvvwp1 znl73k7

3 Mar 22

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

4:16pm

8-K

EX-99.1

ihoejco 76

10 Jan 22

Regulation FD Disclosure

7:01am

8-K

EX-99.1

ztav4idr6 91k1

1 Dec 21

Regulation FD Disclosure

9:01am

8-K

EX-99.1

2erbevn63u19ryl8im61

4 Nov 21

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

4:19pm

8-K

EX-99.1

25v2ms 2g9yt

9 Aug 21

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results

8:45am

10-Q

ye5ywtdfe u8kiczuyw

10 May 21

Quarterly report

4:45pm

8-K

EX-99.1

6p8o1br4 kz5hedn058e

10 May 21

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results

4:15pm

S-1

EX-10.15

1qnhzqo

19 Feb 21

IPO registration

5:30pm

DRS

EX-10.13

ulf 3l4j9m

15 Dec 20

Draft registration statement

12:00am